Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic
Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy
Antiviral agents -- Effectiveness. : Antivirals for pandemic influenza : guidance on developing a distribution and dispensing program / Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies
Antiviral Agents -- pharmacokinetics. : Pharmacometric approaches to optimize use of drugs and dialysis treatments in patients with chronic kidney disease / Marc Pfister
Antiviral Agents -- supply & distribution. : Antivirals for pandemic influenza : guidance on developing a distribution and dispensing program / Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies
2008
1
Antiviral agents -- Synthesis. : Antibiotics and antiviral compounds : chemical synthesis and modification / edited by Karsten Krohn, Herbert A. Kirst, and Hans Maag
1993
1
Antiviral agents -- Synthesis -- Congresses. : Antibiotics and antiviral compounds : chemical synthesis and modification / edited by Karsten Krohn, Herbert A. Kirst, and Hans Maag
Antiviral agents -- Therapeutic use -- Congresses. : Exploring the role of antiviral drugs in the eradication of polio : workshop report / Committee on Development of a Polio Antiviral and Its Potential Role in Global Poliomyelitis Eradication, Board on Life Sciences, Division on Earth and Life Studies, National Research Council of the National Academies
2006
1
Antiviral agents -- United States -- Congresses. : Public engagement on facilitating access to antiviral medications and information in an influenza pandemic : workshop series summary / Barbara Fain, Kristin Viswanathan, and Bruce M. Altevogt, rapporteurs
A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia
The ability of viruses to resist or to become tolerant to chemotherapeutic agents or antiviral agents. This resistance is acquired through gene mutation
The ability of viruses to resist or to become tolerant to chemotherapeutic agents or antiviral agents. This resistance is acquired through gene mutation
